US3853923A - 2-substituted-(2-hydroxy-3-lower alkaminopropoxy)-benzofurans - Google Patents

2-substituted-(2-hydroxy-3-lower alkaminopropoxy)-benzofurans Download PDF

Info

Publication number
US3853923A
US3853923A US00251454A US25145472A US3853923A US 3853923 A US3853923 A US 3853923A US 00251454 A US00251454 A US 00251454A US 25145472 A US25145472 A US 25145472A US 3853923 A US3853923 A US 3853923A
Authority
US
United States
Prior art keywords
benzofuran
hydroxy
acetyl
mixture
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US00251454A
Inventor
K Ito
M Ikemoto
K Kimura
T Nakanishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaken Pharmaceutical Co Ltd
Original Assignee
Kakenyaku Kako KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP5233371A external-priority patent/JPS5020062B1/ja
Priority claimed from JP8610971A external-priority patent/JPS5020063B2/ja
Priority claimed from JP439572A external-priority patent/JPS5529993B2/ja
Application filed by Kakenyaku Kako KK filed Critical Kakenyaku Kako KK
Application granted granted Critical
Publication of US3853923A publication Critical patent/US3853923A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/86Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Benzofuran derivatives of the general formula:

AND THEIR PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALTS HAVING SUPERIOR PHARMACOLOGICAL ACTIVITIES FOR DISEASES IN CIRCULATORY SYSTEM OR PERIPHERAL NERVOUS SYSTEM, AND METHOD FOR THE PREPARATION OF THE SAID BENZOFURAN DERIVATIVES.

Description

United States Patent 1191 [111 3,853,923 Ito et al. Dec. 10, 1974 2-SUBSTITUTED-(2-HYDROXY-3-LOWER [56] References Cited ALKAMINOPROPOXY)-BENZOFURANS UNITED STATES PATENTS [75] Inv ntors: K yos i It t M sah k 3,340,266 9/1967 Howe et al 260/3462 R Ikemoto, Honmachi; Kazuhiko Otsu; Temo Nakanishi, Primary Examiner-John D. Randolph Kyoto an of Japan Assistant Examiner-Bernard Dentz [73] Assignee: Kakenyaku Kako Co., Ltd., Tokyo, Attorney Agent or Firmclene Upchurch Japan 22 Filed: May 8, 1972 [57] ABSTRACT [211 App. No: 251,454 Benzofuran derivatives oBf the general formula:
[30] Foreign Application Priority Data OCHZCH CHZNHR May 13, l97l Japan 46-32145 A H July 14, 1971 Japan 46-52333 0 Oct. 28, 1971 Japan 46-86109 nd h ir ph rm ti lly ccep able cid addition Jan. 6, 1972 Japan 47-4395 salts having superior pharmacological activities for diseases in circulatory system or peripheral nervous [52] US. Cl 260/346.2 R, 260/340.9, 424/285 System, and method for the preparation of the said [51] Int. Cl C07d 5/42 benzofuran derivatives. [58] Field of Search 260/3462 R 21 Claims, No Drawings 1 Z-SUBSTITUTED-(Z-HXQROXY-B-LOWER ALKAMINOPQBPGXY)-BENZOFURANS The present invention relatesto novel benzofuran derivatives and their pharmaceutically acceptable acid addition salt, and further to methods for the preparation thereof and pharmaceutical composition containing the benzofuran derivatives.
There hitherto have been known many kinds of medi caments for treating diseases in circulatory system but has still been desired further superior medicament.
It has been researched to find out other compounds useful for treating diseases in circulatory system. As a result, it has now beenfound out that some novel benzofuran derivatives and their pharmaceutically acceptable acid addition salts possess superior pharmacolog-' oomonommm A n wherein A is -COR',
--JJ=NR,
or ethyl group; B is hydrogen atom when A is COR' or R! -J:=NR,
or -COR" substituted at 3 or 4 position of benzofuran nucleus when A is ethyl group; R is an alkyl group hav-v ing 1 to carbon atoms; R is an alkyl group having I to 4 carbon atoms, an alkoxy group having I to 3 carbon atoms or phenyl group; R" is an alkyl group having l to 4 carbon atoms, phenyl group or phenylalkyl group wherein the alkyl moiety has 1 to 2 carbon atoms; and the group is substituted at 3.4.5.6 or 7 position of benzofuran nucleus.
- Suitable examples of the group --COR' are an alkanoyl group wherein the alkyl moiety means a straight or branched alkyl group having 1 to'4 carbon atoms, such as methyl, ethyl. propyl, isopropyl. butyl. isobutyl, secondary butyl or tertiary butyl; an alkoxycarbonyl group wherein the alkoxy moiety means an alkoxy group having 1 to 3 carbon atoms, such as methoxy, ethoxy or propoxy; and benzoyl group. Suitable examples of the group COR" are an alkanoyl group wherein the alkyl moiety means a straight or branched alkyl group having 1 to 4 carbon atoms, such as methyl, ethyl, propyl, isopropyl, butyl or isobutyl; benzoyl group; and a phenylalkanoyl group wherein the alkyl moiety means an alkyl group having 1 to 2 carbon atoms, such as methyl or ethyl.' The alkyl group defined as R is a straight or branched alkyl group having 1 to 5 carbon atoms, such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, secondary butyl, tertiary butyl or amyl, preferably a branched alkyl group having 3 to 4 carbon atoms, such as isopropyl, isobutyl, secondary butyl or tertiary butyl.
Suitable examples of the present benzofuran derivatives are 2-acetyl-7-(2-hydroxy-3- isopropylaminopropoxy)benzofuran, 2-acetyl-7-( 2- hydroxy-3-tertiary butylaminopropoxy)benzofuran, 2- acetyl-4-(2-hydroxy-3-tertiary butylaminopropoxy)- benzofuran, 2-carbethoxy-7-(2-hydroxy-3- isopropylaminopropoxy)benzofuran, 2-benzoyl-7-(2- hydroxy-3-isopropylaminopropoxy)benzofuran, 2-
acetyl-5(2-hydroxy-3-isopropylaminopropoxy)benbenzofuran, 2-ethyl-3-acetyl-5-(2-hydroxy-3-tertiary butylaminopropoxy)benzofuran, 2-( l isopropylimino)ethyl-7-( 2-hydroxy-3- isopropylaminopropoxy )benzofuran. 2-( lisopropylimino)ethyl-4-(2-hydroxy-3- isopropylaminopropoxy)-benzofuran. 2-( l-secondary butylimino)ethyl-4-(Lhydroxy-S-secondary butylaminopropoxy)benzofuran. 2-( l-isopropylimino ethyl-S-(2-hydroxy-3-isopropylaminopropoxy)benzofuran, 2-( l-secondary butylimino )ethyl-6-( 2- hydroxy-3-secondary butylaminopropoxy)benzofuran and 2-( l-amylimino)ethyl-5-(2-hydroxy-3- amylaminopropoxy)benzofuran. Most suitable examples are 2-acetyl-7-(2-hydroxy-3- isopropylaminopropoxy)benzofuran. 2-acetyl-7-(2- hydroxy-3-tertiary butylaminopropoxy)benzofuran. 2- carbethoxy-7-( Z-hydroxy-3-isopropylaminopropoxy benzofuran, 2-benzoyl-7-(2-hydroxy-3- isopropylaminopropoxy )benzofuran. 2-acetyl-7-( 2- hydroxy-3-secondary butylaminopropoxy)benzofuran,
2-acetyl-4-(2-hydroxy-3-tertiary butylaminopropoxy)- (II) is reacted with a primary amine (III) to give the deis used, his preferably carried out in the presence of a benzofuran, 2-( l-isopropylimino )ethyI-7-(2-hydroxy- 3-isopropylaminopropoxy)-benzofuran and 2-H- isopropylimino )ethyl-4-( 2-hydroxy-3- isopropylaminopropoxy)benzofuran.
A method for the preparation of the present benzofu- 5 ran derivatives (I) can be illustrated as'follows:
l l oomx HzNR &
or) (III and A, B and R are the same as defined above.
In the above method, an alkoxybenzofuran derivative sired benzofuran derivative (I). The reaction can be carried out at a room temperature, or at an elevated temperature, optionally under a pressure, in a suitable organic solventsuch as methanol, ethanol, benzene 0r toluene. The reaction temperature is usually about 60 to about ll0C. and the reaction period is about minutes to 10 several hours,-preferably about minutes to about 10 hours. When A in the starting alkoxybenzofuran derivative (II) is -COR' and the reaction condition is severe, for instance, the reaction is carried out under a pressure, eg 2 to atmospheres, preferably 3 to 10 atmospheres for a relatively long period, e.g. l() to 15 hours, the group COR' is also reacted with the primary amine (III) to give a group -t i=rvn .While the reaction can be carried out at an ordinary pressure when the reaction period is longer, it is preferable to carry out under apressure. If the starting alkox- 50 ybenzofuran derivative (ll) wherein X is per one mole of the alkoxybenzofuran derivative (II), but it is preferable to use excess amount of the primary the amine (III) which functions both. asreactant and solvent.
In the above method there may be used, instead of an alkoxybenzofuran derivative (II), hydroxybenzofuran derivative (IV) and epichlorohydrin (V). That is, the reaction may be also carried out by heating a mixture of hydroxybenzofuran derivative (IV), epichlorohydrin (V) and primary amine (III) at about 60 to about 1 10C. for 10 minutes to 10 several hours in a suitable solvent such as water, methanol, ethanol, dioxane, acetone, N,N-dimethylformamide or a mixture thereof.
The starting alkoxybenzofuran derivative (II) can'be prepared by the following method:
l OOHzX A 0/ wherein A, B and X are the same as defined above.
In the method, a hydroxybenzofuran derivative (IV) is reacted with epichlorohydrin (V) to give an alkoxybenzofuran derivative (Ii). The reaction can be carried out by heating the reactants, optionally under a pressure, preferably in the presence of a catalyst selected from the group consisting of secondary or tertiary amines and mineral acid salts thereof; e.g. dimethylamine, diethylamine, trimethylamine, triethylamine, piperidine, pyridine, and the like. The reaction temperature is 50 to 120C, preferably to C. and the reaction period is'several tens minutes to l0 several hours, preferably l to 5 hours. The reaction can be carried out without solvent, but if necessary, in a suitable organic solvent such as ethanol or N,N-dimethylformamide, According to the above reaction, (2,3-epoxypropoxy)-benzofuran derivative (X is a group is mainly obtained and a small amount of (2 hydroxy-3- chloro)-propoxybenzofuran derivative (X is a group is optionally mixed with '(2,3-epoxypropoxy)benzofuran derivative, but the mixture as it is can be used for subsequent reaction. If desired, the (2,3-epoxypropoxy)benzofuran derivative ybenzofuran derivative by treating with hydrochloric acid in a suitable organic solvent such as chloroform.
The hydroxybenzofuran derivative (IV) wherein B is ,COR" is a novel compound and can be readily pre- I pared by reacting 2-ethyl-hydroxybenzofuran, in which the hydroxylgroup is protected by an acyl group or a lower alkyl group, with a conventional acylating agent such as acid chloride or acid anhydride in a suitable organic solvent such as carbon disulfide, nitroethane or nitrobenzene in a presence of a catalyst such as Lewis can be readily converted into (2-hydroxy-3-chloro) propoxacid, e.g. anhydrous aluminum chloride or anhydrous tin tetrachloride to introduce an acyl group at 3 or 4 position of benzofuran nucleus and removing the acyl group or alkyl group substituted on hydroxyl group by a conventional method, for example, by treating the resultant with alkali metal hydroxide, or with anhydrous aluminum chloride or anhydrous tin tetrachloride.
Alternatively, the present benzofuran derivative (1) can be also prepared by the following methods:
1. 2-a1kanoyl-7-(2-hydroxy-3-aminopropoxy)benzofuran is reacted with an alkyl halide at about 60 to about 100C. for a few hours to several hours in a suitable solvent such as methanol or ethanol.
2. 2-alkanoyl-7-hydroxybenzofuran or its alkali metal salt is reacted with l-a1ky1amino-3-chloro-2-propanol at about 70 to about 100C., optionally under a pressure for several hours to several tens hours.
3. 3-alky1-5-(2-alkanoyl-7-benzofuranoxymethyl)- oxazolidine or its Z-phenyl derivative is treated with an acid such as hydrochloric acid or an alkali metal hydroxide such as sodium hydroxide at about 70 to about 150C. for several tens minutes to several hours.
4. 2-alkanoy1-7-[2-hydroxy-3-(N-acyl-N-alkyl)- aminopropoxy)benzofuran is treated with an acid such as hydrochloric acid at about 70 to about 80C. for a few hours to several hours.
5. 2-(1-ethy1enedioxy)ethyl-7-(2-oxo-3- alkylaminopropoxy)benzofuran is reduced by a reducing agent such as lithium aluminum hydride, sodium borohydride or hydrogen gas-palladium catalyst or hydrogen gas-platinum catalyst at a room temperature for several tens minutes to a few hours and then the resultant is hydrolyzed with an acid such as hydrochloric acid.
6. 2-( l-cthylenedioxy)ethyl-7-[ 2-hydroxy-3-(N- hcnzyl-N-alkyl)aminopropoxy]benzofuran is reduced by hydrogen gas-palladium catalyst at a room temperature and then the resultant is hydrolyzed with an acid such as hydrochloric acid.
7. 2-( l-ethylenedioxy)ethyl-7-(2hydroxy-3- aminopropoxy)benzofuran, 2-(1-ethylenedioxy)ethyl- 7-(2-oxo-3-hydroxyiminopropoxy)benzofuran or 2-(1- ethylenedioxy)-ethyl-7-(2-cyano-2-hydroxyethoxy)- benzofuran is reacted with a ketone such as acetone at a lower temperature or at a room temperature under a condition of reduction, for instance, in the presence of a reducing agent such as lithium aluminum hydride or sodium borohydride or with adding hydrogen gas in the presence of a catalyst such as palladium or platinum and then the resultant is hydrolyzed with an acid such as hydrochloric acid.
8. 2-(1-ethylenedioxy)ethyl-7-(2,3-dioxopropoxy)- benzofuran is reacted with a primary amine at a lower temperature under a condition of reduction as mentioned in item (7) and then the resultant is hydrolyzed with an acid such as hydrochloric acid.
When the present benzofuran derivatives (1) prepared by the above method are a free base, they can be readily converted into their pharmaceutically acceptable acid addition salts by a conventional method, e.g. by treating the free base with an acid, if necessary, in a suitable organic solvent such as methanol or ethanol. The acid may be an inorganic acid such as hydrochloric acid, sulfuric acid or nitric acid or an organic acid such as oxalic acid, acetic acid, succinic acid, malic acid, maleic acid, tartaric acid or tannic acid. In the present invention the benzofuran derivatives (I) can be racemic, dextroor levo-form.
The benzofuran detivatives (I) and their pharmaceutically acceptable acid addition salts of the invention possess superior pharmacological activities for diseases in circulatory system or peripheral nervous system, for instance, they show superior B-adrenergic blocking activity and local anesthetic acitvit, and on the other hand they show low toxicity. Therefore, they are useful as medicaments, especially for prevention and treatment of heart diseases such as cardiac arrhythmias and angina pectoris and of hypertension.
The present benzofuran derivatives (1) and their pharmaceutically acceptable acid addition salts can be administered in parenteral or oral route by conventional methods with conventional pharmaceutical carriers in humans and animals. Oral administration by the use of tablets, capsules, powders or in liquid form such as suspensions, solutions, emulsions or syrups in particularly advantageous.
The preparation of the present benzofuran derivatives and their pharmaceutically acceptable acid addition salts is illustrated by the following examples.
EXAMPLE 1 To 8.8 g. of 2-acetyl-7-hydroxybenzofuran were added ml. of epichlorohydrin and 0.2 g. of piperidine hydrochloride and the mixture was heated at.
C. for 3 hours. After the reaction, the excess of epichlorohydrin was evaporated and the resultant was product was dissolved in 30 ml. of ethanol and to the solution was added 10 ml. of isopropylamine. After refluxing the mixture for 40 minutes, the solvent was evaporated from the reaction mixture. The resulting residue was recrystallized from cyclohexane-acetone to give 6 g. of 2-acetyl-7-(2-hydroxy-3- isopropylaminopropoxy)benzofuran having a melting point of l 15C.
The product obtained was dissolved in 10 ml. of 3 N hydrochloric acid and thereto 50 ml. of ethanol was added. The mixture was heated under a reduced pressure and the solvent was evaporated. The resulting residue was recrystallized from ethyl acetate to give its hydrochloride having a melting point of 163C.
Analysis for C, H ,O N-HC1:
Calcd. C 58.62, H 6.76, N 4.27; Found C 58.32, H 6.92, N 4.07.
EXAMPLE 2 In 50 ml. of ethanol was dissolved 6 g. of 2-acetyl-7- (2,3-epoxypropoxy)benzofuran having a boiling point of l75-6C./0.7 mmHg prepared in the same manner as described in Example 1 and thereto 10 ml. of ten.- butylamine was added. After refluxing the mixture for 40 minutes, the solvent was evaporated. The resulting residue was recrystallized from cyclohexane to give 6.3 g. of 2-acety1-7-(2-hydroxy-3-tert.-butylaminopropoxy)-benzofuran having a melting point of C.
The product obtained was converted into its hydrochloride having a melting point of 178C. in the same manner as described in Example 1.
Analysis for c,,H ,0,N-Hcl:
Calcd. C 59.73, H 7.08, N 4.10;
Found C 59.86, H 6.90, N 3.95.
EXAMPLE 3 To 3 g. of 2-acetyl-4-hydroxybenzofuran were added 30 ml. of epichlorohydrin and mg. of piperidine hydrochloride and the mixture was heated at 105C. for 2 hours. After the reaction, the excess of epichlorohydrin was evaporated. The resulting residue was recrystallized from petroleum ether-ethanol to give 3 g. of 2- acetyl-4-(2,3-epoxypropoxy)benzofuran having a melting point of 103C. 1.2g. of the product thus obtained,
was dissolved. in 12 ml. of ethanol and thereto was added ml. of tert.-butylamine. The mixture was refluxed for 1 hour. The solvent .was evaporated from the reaction mixture to give 1.5 g. of crude 2-acetyl-4-(2- hydroxy-3-tert.-butylaminopropoxy)benzofuran. The
product thus obtained was converted into 1.3 g. of its hydrochloride having a melting point of 232C. in the same manner as in Example 1. Analysis for C H O N'HCl: Calcd. C. 59.73, H 7.08, N 4.10; Found (%):C 59.68, H 7.16, N 4.20.
EXAMPLE 4 To 1.2 g.-of 2-carbethoxy-7-hydroxybenzofuran were added 30 ml. of epichlorohydrin and 120 mg. of piperidine hydrochloride. The mixture was heated at l C. for 2 hours. After the reaction, the excess of epichlorohydrin was evaporated and the residue was distilled to give 1.2 g. of 2-carbethoxy-7-(2,3-epoxypropoxy benzofuran having a boiling point of 175178C./0.7 mmHg. 0.5 g. ofthepr'oductthus obtained was dissolved in 5 ml. of ethanol and thereto was added m1. of isopropylamine. The mixture was refluxed for 1 hour and then the solvent was evaporated from the reaction -mixture to give 0.5 g. of crude 2-carbethoxy-7-(2- hydroxy-3-isoprop'ylaminopropoxy)-benzofuran. The crude product was recrystallized from cyclohexaneacetone to give a purified product having a melting point of 109C.
The product thus obtained was converted into 0.4 g. of its hydrochloride having a melting point of 133C. in the same manner as described in Example 1.
Analysis for C HggOgN'HClI Calcd. C 57.06, H 6.76, N 3.92;
Found C 57.23, H 6.85, N 3.80.
EXAMPLE 5 h To 2.4 g. of 2-benzoyl-7-hydroxybenzofuran were added 30 ml. of epichlorohydrin and 150 mg. of piperi- .dine hydrochloride. The mixture was refluxed for 3 hoursQAfter the reaction, the excess of epichlorohydrin was evaporated. After collecting the materials dissolved into ether from the residue, the ether was evaporated to give 2.2g. of2-benzoyl-7-(2,3-epoxypropoxy)- benzofuran as an oily substance. To the product thus obtained were added 30 ml. of ethanol and 3 g. of isopropylamine. After refluxing the mixture for 30 minutes, the solvent was evaporated. The resulting residue was recrystallized from a small amount of ether to give 2 g. of 2-benzoyl'7-(2-hydroxy-3- isopropylaminopropoxy)benzofuran having a melting point of 107C.
Analysis for C,,H -,O N: Calcd. C 71.39, H 6.56, N 3.96; Found C H 6.43, N 4.17.
EXAMPLE 6 To 2.3 g. of 2-acetyl-5-(2,3-epoxypropoxy)- benzofuran which was prepared'by using 2 acetyl-5- hydroxybenzofuran and epichlorohydrin in the same manner as described in Example 3 were added 20 ml.
of ethanol and 5 m1. of isopropylamine. The mixturev was refluxed for 40 minutes and then the excess of isopropylamine and ethanol were evaporated. To the resulting residue were added 5 ml. of diluted hydrochloric acid and further ethanol. The mixture was distilled undera reduced pressure. The residue was recrystallizedfromethyl acetate-ethanol to give 2.5 g. of 2- acetyl-5-(2-hydroxy-3-isopropylaminopropoxy)benzofuran hydrochloride having a melting point of 175C.
Analysis for C H O N'HCl: Calcd. C 58.62, H 6.76, N 4.27; Found C 58.41, H 6.95, N 4.03.
EXAMPLE 7 In 10 m1.-of ethanolwas dissolved 0.7 g. of Z-acetyl- 7-(2,3 epoxypropoxy)benzofuran prepared in the same manner as described in Example 1 and thereto was 7 added 1 g. of sec-butylamine. After refluxing the mixture for 30 minutes, the solvent was evaporated. The resulting residue was recrystallized from cyclohexaneacetone to give 0.8 g. of 2-acetyl-7-(2-hydroxy-3-sec.- butylaminopropoxy)benzofuran having a melting point of 82C. 1
Analysis for C I-1 0M:
Calcd. C 66.86, H 7.59, N 4.59;
Found C 66.74, H 7.62, N 4.47.
. EXAMPLE 8. To- 10 g. of 2-acetyl-3-hydroxybenzofuran were added 50 m1. of epichlorohydrin and 50 mg. of piperidine hydrochloride. The mixture was refluxed for 3 hours and the excess of epichlorohydrin was evaporated. The resulting residue was recrystallized from ethanol to give 6.5 g. of 2-aeetyl-3-(2,3-epoxypropoxy)benzofuran having a melting point of l 05.5C. 2.2 g.
- of the product thus obtained was dissolved in 10 ml. of
ethanol and thereto was added 4 g. of ten-butylamine. After refluxing the mixture for 30 minutes, the solvent was evaporated under a reduced pressure. The resulting residue was recrystallized from cyclohexane to give 2 g. of 2-acetyl-3-( 2-hydroxy-3-tert.- butylaminopropoxy)benzofuran having a melting point of 106.5C
Analysis for C,-,H O N:
Calcd. C 66.86, H 7.59, N 4.59;
Found C 66.93, H 7.82,.N 4.44.
EXAMPLE 9 benzofuran having a meltingpoint of 118C.
Analysis for C H O.,N: Calcd. C 66.86, H 7.59, N 4.59; Found C 66.65, H 7.71, N 4.63.
EXAMPLE 10 In 10 ml. of epichlorohydrin was dissolved l g. of 2- ethyl-4-acetyl-7-hydroxybenzofuran and thereto was added 50 mg. of piperidine hydrochloride. The mixture was refluxed for 2 hours and then distilled to give 0.9
g. of 2-ethyl-4-acetyl-7-(2,3-epoxypropoxy)benzofuran. 0.4 g. of the product thus obtained and 0.2 g. of
a small amount of acetone to give 0.4 g. of 2-ethyl-4- acetyl-7-(2-hydroxy-3-isopropylaminopropoxy)benzofuran having a melting point of 1 C. Analysis for C H O N:
Calcd. C 67.69, H 7.89, N4.39;
Found C 67.49, H 7.86, N 4.32.
The 2-ethyl-4-acetyl-7-( 2-hydroxy-3- isopropylaminopropoxy)benzofuran thus obtained was dissolved in a diluted hydrochloric acid and thereto was added ethanol. The mixture was condensed under a reduced pressure and the resulting residue was recrystallized from ethyl acetate-ethanol to give its hydrochloride having a melting point of 147C.
Calcd. C 60.75, H 7.36, N 3.94;
Found C 60.61, H 7.51, N 3.99.
The starting 2-ethyl 4-acetyl-7-hydroxybenzofuran was prepared as follows:
To 15 ml. of chlorobenzene was dissolved 1.5 g. of 2-ethyl-4-acetyl-7-methoxybenzofuran (Bull. Soc. Chim. France, 1971', page 2072) and thereto was gradually added with agitation 2 g. of finely divided anhydrous aluminum chloride at a room temperature. The mixture was heated at 70 to 80C. for 2 hours. To the reaction mixture were added a diluted hydrochloric acid and ice. The precipitated crystallines were separated by filtration and recrystallized from benzene to give 1 g. of the desired product having a melting point of 156 to 157C.
EXAMPLE 11 To 13 ml. of ethanol were added 1.3 g. of 2-ethyl-4- acetyl-7-(2,3-epoxypropoxy)benzofuran prepared in the same manner as described in Example 10 and 0.7 g. of tert.-butylamine. After refluxing the mixture for minutes, the solvent was evaporated under a reduced pressure. The resulting residue was recrystallized from cyclohexane containing a small amount of acetone to give 1.4 g. of 2-ethyl-4-acetyl-7-(2-hydroxy- 3-tert.-buty1aminopropoxy)benzofuran having a melting point of 119 The product thus obtained was treated hydrochloric acid in the same manner as described in Example 10 and the resulting crude crystallines were recrystallized from ethyl acetate-ethanol to give its hydrochloride having a melting point of 171 Analysis for C H O N'HCI;
Calcd. C 61.70, H 7.63, N 3.79;
Found C 61.58, H 7.55, N 3.86.
EXAMPLE 12 In 15 m1. of epichlorohydrin was dissolved 0.9 g. of 2-ethyl-4-propionyl-7-hydroxybenzoturan and thereto was added 50 mg. of piperidine hydrochloride. The mixture was refluxed for 2 hours and then distilled to give 0.8 g. of 2-ethyl-4-propionyl-7-(2,3-epoxypropoxy)-benzofuran. The product thus obtained and 0.65 g. of isopropylamine were added to 10 ml. of ethanol. After refluxing the mixture for 20 minutes, the solvent was evaporated under a reduced pressure. The resulting residue was recrystallized from cyclohexane to give 0.8 g. of 2-ethyl-4-propionyl-7-(2-hydroxy-3-isopropylaminopropoxy)benzofuran having a melting point of C.
Analysis for C H O N:
Calcd. C 68.44, H 8.16, N 4.20;
Found C 68.57, H 8.12, N 4.27.
EXAMPLE 13 To 10 m1. of ethanol were added 1 g. of 2-ethyl-4- propiony1-7-(2,3-epoxypropoxy)benzofuran prepared in the same manner as described in Example 12 and 0.8 g. of sec.-butylamine. After refluxing the mixture for 20 minutes, the solvent was evaporated under a reduced pressure. The resulting residue was recrystallized from cyclohexane to give 0.9 g. of 2-ethyl-4-propionyl-7-(2- hydroxy-3-sec.-butylaminopropoxy)benzofuran having a melting point of 94C.
Analysis for C H O N:
Ca1cd.(%):C 69.13, H 8.41, N 4.03;
Found C 68.97, H 8.36, N 4.15.
EXAMPLE 14 In 13 ml. of epichlorohydrin was dissolved 0.8 g. of 2-ethyl 4-benzoyl-7-hydroxybenzofuran and thereto was added 40 mg. of piperidine hydrochloride. After refluxing the mixture for 2 hours, the reaction mixture was distilled under a reduced pressure to give 0.8 g. of 2-ethyl-4-benzoyl-7-(2,3-epoxypropoxy)benzofuran. The product thus obtained and 0.6 g. of isopropylamine were added to 10ml. of ethanol. After refluxing the mixture for 20 minutes, the solvent was evaporated under a reduced pressure. The resulting residue was recrystallized from cyclohexane to give 0.7 g. of 2-ethyl- 4-benzoyl-7-(2-hydroxy-3-isopropylaminopropoxy)- benzofuran having a melting point of 94C.
Analysis for C H O N:
Ca1cd.(%):C 72.42, H 7.13, N 3.67;
Found C 72.27, H 7.11, N 3.75.
EXAMPLE 15 To 10 ml. of ethanol were added 1 g. of 2-ethyl-4- benzoyl-7-(2,3-epoxypropoxy)benzofuran prepared in the same manner as described in Example 14 and 0.7 g. of tert.-butylamine. After refluxing the mixture for 20 minutes, the solvent was evaporated under a reduced pressure. The resulting redidue was treated with hydrochloric acid in the same manner as described in Example 10. The precipitated crude crystallines were recrystallized from ethyl acetate-ethanol to give 1.2 g. of 2-ethyl-4-benzoyl-7-(2-hydroxy-3tert.- butylaminopropoxy)benzofuran hydrochloride having a melting point of 182C.
Analysis for C H O N-HCl:
Calcd. C 66.74, H 7.00, N 3.24;
Found C 6685, H 6.91, N 3.35.
EXAMPLE 16 In 15 ml. of epichlorohydrin was dissolved 0.84 g. of 2ethyl-4-phenylacetyl-7-hydroxybenzofuran and thereto was added 50 mg. of piperidine hydrochloride. After refluxing the mixture for 2 hours, the reaction mixture was distilled under a reduced pressure. The resulting residue was dissolved in ether. The ether layer was taken out and ether was evaporated to give 0.7 g. of 2-ethyl-4-phenylacetyl-7-(2,3-epoxypropoxy)benzofuran. The product thus obtained and 0.5 g. of isoisopropylaminopropoxy)benzofuran having a melting point of 127C.
Analysis for C24H2904N1 Calcd. C 72.88, H 7.39, N 3.54; Found C 72.95, H 7.31, N 3.45.
EXAMPLE 17 To 10 ml. of ethanol were added l g. of 2-ethyl-4- pheny1acety1-7-(2,3-epoxypropoxy )benzofuran and 0.7 g. of sec.-butylamine. After refluxing the mixture for 20 minutes, the solvent was evaporated under a reduced i EXAMPLE is In 40 ml. of epichlorohydrin was dissolved 4 g. of 2- ethyl-4-acetyl-5-hydroxybenzofuran and thereto was added 0.1 g. of piperidine hydrochloride. After refluxing the mixture for 4 hours, the reaction mixture was distilled under a reduced pressure. The resulting residue was extracted .with ether. From the ether layer, ether was evaporated and the residue was washed with petroleum ether to give 4.2 g. of 2-ethyl-4-acetyl-5- (2,3-epoxypropoxy)benzofuran. 1.5 g. of the product thus obtained and l g. of tert.-butylamine were added to 20 m1. of ethanol. After refluxing the mixture for 20 minutes, the solvent was evaporated under a reduced pressure. The resulting residue was extracted with a diluted hydrochloric acid. The extract was made alkaline with a diluted aqueous sodium hydroxide solution. The resulting oily substance was extracted with ether. From the ether layer, ether was evaporated to give 1.2 g. of oily substance. The oily substance was dissolved in a diluted hydrochloric acid and thereto was added ethanol. After condensing the mixture under a reduced pressure, the resulting residue was recrystallized from ethyl acetate-ether to give 1.2 g. of 2-ethy1-4-acetyl-5- (2-hydroxy-3-tert.-butylaminopropoxy)benzofuran hydrochloride having a melting point of 149C.
Analysis for C 9H270 N'HCli Calcd. C 61.70, H 7.63, N 3.79;
Found C 61.53, H- 7.58, N 3.65.
The starting 2-ethyl-4-acetyl-5-hydroxybenzofuran was prepared as follows:
In 30 m1. of carbon disulfide was dissolved 3.3 g. of 2-ethyl-5-n-butoxybenzofuran and thereto was added 1.35 g. of acetyl chloride. After being further added 4.7 g. of anhydrous tin tetrachloride at to C., the mixture was reacted at a room temperature for 3 hours, and then the solvent was evaporated. The resulting residue was dissolved in 30 g ml. of chlorobenzeneand thereto was added 3.2 g. of anhydrous aluminum chloride at a room temperature. The mixture was warmed at 40 to 50C. for 2 hours. To the reaction mixture was added a cold diluted hydrochloric acid and then the mixture was extracted with ether. The ether layer was separated, dried and then ether was evaporated under a reduced pressure. To the resulting residue was added hot petroleum ether and extracted therewith. The petroleum ether layer was cooled to give 0.6 g. of the desired I product having a melting point of 1 19.5 to 121.5C.
EXAMPLE 19 In 12 ml. of epichlorohydrin was dissolved 1 g. of 2- ethyl-4-benzoyl-5-hydroxybenzofuran and thereto was added mg. of piperidine hydrochloride. After refluxing the mixture for 3 hours, the reaction mixture was distilled under a reduced pressure. The resulting residue was extracted with ether. From the ether layer,
ether was evaporated to give 1.2 g. of 2-ethyl-4- benzoyl-5-(2,3-epoxypropoxy)benzofuran as an oily substance. 1 g. of the product thus obtained and 0.7 g. of isopropylamine were added to 10 ml. of ethanol. After refluxing the mixture for 30 minutes, the solvent was evaporated under a reduced pressure. The resulting residue was recrystallized from cyclohexane to give 0.8 g. of 2-ethyl-4-benzoyl-5-(2-hydroxy-3- isopropylaminopropoxy)benzofuran having a melting point of 106C.
Analysis for C H O N:
Calcd. C 77.42, H 7.13, N 3.67;
Found C 77.57, H 7.21, N358.
EXAMPLE 20 To 2 g. of 2-ethyl-3-acetyl-7-hydroxybenzofuran were added 40 ml. of epichlorohydrin and 0.1 g. of piperidine hydrochloride. After refluxing the mixture for 2 hours, the reaction mixture wassubjected to distillation under a reduced pressure to give 2.8 g. of crude 2- ethyl-3-acetyl-7-(2,3-epoxypropoxy)benzofuran. The product thus obtained and 7 ml. of tert.-butylamine were added to 20 ml. of ethanol. After refluxing the mixture for 30 minutes, the solvent was evaporated under a reduced pressure. The resulting residue was recrystallized from petroleum ether to give 1.2 g. of 2- ethyl-3-acetyl-7-(2-hydroxy-3-tert.-butylaminopropoxy)benzofuran having a melting point of 97 to 98C.
Analysis for C,,,H O N:
Calcd. C 68.44, H 8.16, N 4.20;
Found C 68.58, H 8.11, N 4.09.
The starting 2-ethyl-3-acetyl-7-hydroxybenzofuran was prepared as follows:
in 70 ml. of anhydrous carbon disulflde was dissolved 4.5 g. of 2-ethyl-7-acetoxybenzofuran, and thereto were further added 2 g. of acetyl chloride and 7 g. of anhydrous tin tetrachloride. The mixture was reacted at a room temperature for 2 hours. To the reaction mixture was added a cold diluted hydrochloric acid to hydrolyze. The organic layer was collected and dried, and then the solvent was evaporated to give 3 g. of crude 2-ethy1'3-acetyl-7-acetoxybenzofuran. To the product thus obtained was added a diluted aqueous sodium hydroxide solution to hydrolyze with warming and the mixture was made acidic with a diluted hydrochloric acid. The precipitated crystallines were separated by filtration and recrystallized from ethanol to give 2 g. of the desired product having a melting point of 173 to 175C.
EXAMPLE 21 To 1.5 g. of 2-ethyl-3-acetyl-5-hydroxybenzofuran were added 30 ml. of epichlorohydrin and 0.1 g. of piperidine hydrochloride. After refluxing the mixture for 2 hours, the reaction mixture was distilled under a reduced pressure to give 2.2 g. of crude 2-ethyl-3-acetyl- -(2,3-epoxypropoxy)benzofuran. The product thus obtained and 5 ml. of tert.-butylamine were added to ml. of ethanol. After refluxing the mixture for 30 minutes, the solvent was evaporated under a reduced pressure. The resulting residue was recrystallized from petroleum ether to give 1 g. of 2-ethyl-3-acetyl-5-(2- hydroxy-3-tert.-butylaminopropoxy)benzofuran having a melting point of 114 to 115C.
Analysis for C H O N:
Ca1cd.(%):C 68.44, H 8.16, N 4.20;
Found C 68.22, H 8.05,'N 4.34.
The starting 2-ethyl-3-acetyl-5-hydroxybenzofuran was prepared as follows:
In ml. of anhydrous carbon disulfide was dissolved 2 g. of 2-ethyl-5-acetoxybenzofuran, and thereto were further added 0.9 g. of acetyl chloride and 3 g. of anhydrous tin tetrachloride. The mixture was reacted at a room temperature for 5 hours. To the reaction mixture was added a cold diluted hydrochloric acid to hydrolyze. The organic layer was taken out and dried, and then the solvent was evaporated to give 1.9 g. of crude 2-ethyl-3-acetyl-5-acetoxybenzofuran. To the product thus obtained was added a diluted aqueous sodium hydroxide solution to hydrolyze with warming and the mixture was made acidic with a diluted hydrochloric acid. The precipitated crystallines were separated by filtration and recrystallized from ethanol to give 1.5 g. of the desired product having a melting point of 177 to 178C.
EXAMPLE 22 A mixture of 214 mg. of potassium salt of 2-acetyl-7- hydroxybenzofuran, 70 mg. of isopropylamine and 0.8 ml. of epichlorohydrin was suspended into 5 ml. of eth anol. After heating the suspension in a sealed tube at 100C. for 20 hours, the reaction mixture was filtered and then the solvent was evaporated under a reduced pressure. The residue was subjected to thin layer chromatography (solid support: Kicselgel PF made by E. Merck, developer: benzene-chloroform-methanol-28% aqueous ammonia( l7:4:3:0.4), eluant: chloroform) for the purification to give 2-acetyl-7-(2-hydroxy-3- isopropylaminopropoxy)benzofuran having a melting point of 115C.
EXAMPLE 23 A mixture of 1.1 g. of 2-acetyl-7-hydroxybenzofuran, 8 ml. of epichlorohydrin and 12.5 mg. of piperidine hydrochloride was heated at 105C. for 3 hours. The reaction mixture was condensed under a reduced pressure and dissolved in chloroform. The solution was washed with a diluted hydrochloric acid and then the solvent was evaporated to give 1.3 g. of 2- acetyl-7-(2-hydroxy-3-chloropropoxy)benzofuran. l g. of the product thus obtained was dissolved in 24 ml. of isopropylamine. The mixture was heated in a sealed tube at 100C. for 12 hours. The reaction mixture was extracted with ether and the ether layer was washed with a diluted aqueous sodium hydroxide solution and then the solvent was evaporated under a reduced pressure. The resulting residue was recrystallized from cyclohexane to give 1 g. of 2-(1-isopropylimino)ethyl-7- (2-hydroxy-3-isopropylaminopropoxy)-benzofuran having a melting point of 103C.
Analysis for c gHggoaNg:
Calcd. C 68.64, H 8.49, N 8.43; Found C 68.40, H 8.22, N 8.42.
EXAMPLE 24 A mixture of 1.8 of 2-acetyl-4-hydroxybenzofuran, 18 ml. of epichlorohydrin and mg. of piperidine hydrochloride was refluxed for 4 hours. After the reaction, the solvent was evaporated under a reduced pressure. The resultant was shaken with 3 ml. of concentrated hydrochloric acid and 10 ml. of chloroform and washed with water and the chloroform layer was concentrated to give 1.4 g. of 2-acetyl-4-(2-hydroxy-3- chloropropoxy)benzofuran. The product thus obtained was dissolved in 50 ml. of isopropylamine. The solution was heated in a sealed tube at C. for 14 hours and then the excess of isopropylamine was evaporated. After collecting the materials dissolved into ether from the residue, the ether was evaporated. The resulting residue was recrystallized from cyclohexane to give 1.3 g. of 2-( l-isopropylimino )ethyl-4-( 2-hydroxy-3- isopropylaminopropoxy)benzofuran having a melting point of C.
Analysis for C H O N Calcd C 68.64, H 8.49, N 8.43;
Found C 68.90, H 8.26, N 8.40.
EXAMPLE 25 In 50 ml. of sec.-butylamine was dissolved 1.4 g. of 2-acetyl-4-(-2-hydroxy-3-chloropropoxy)benzofuran prepared in the same manner as described in Example 24. The solution was heated in a sealed tube at 105C. for 14 hours and then the excess of sec.-butylamine was evaporated. After collecting the materials dissolved into ether from the residue, ether was evaporated. The resulting residue was recrystallized from petroleum ether to give 1.3 g. of 2-(1-sec.-butylimino)ethyl-4-(2- hydroxy-3-sec.-butylaminopropoxy)benzofuran having a melting point of 88C. Analysis for C,,H,,0,N,.
.Calcd. C 69.97, H 8.95, N 7.77;
Found C 69.69, H 8.87, N 7.91.
EXAMPLE 26 A mixture of 1.8 g. benzofuran, 18 ml. of epichlorohydrin and 100 mg. of piperidine hydrochloride was refluxed for 4 hours and then the solvent was evaporated. After collecting the materials dissolved into ether from the residue, ether was evaporated. The resultant was shaken with 10 ml. of chloroform and 3 ml. of concentrated hydrochloric acid and washed with water. The chloroform layer was condensed to give 1.4 g. of 2-acetyl-5-(2-hydroxy-3- chloropropoxy)benzofuran. The product thus obtained was dissolved in 50 ml. of isopropylamine. The solution was heated in a sealed tube at 105C. for 14 hours and then the excess of isopropylamine was evaporated. After collecting the materials dissolved into ether from the residue, ether was evaporated. The resulting resi-. due was recrystallized from petroleum ether to give 1 g. of 2-( l-isopropylimino)ethyl-5-(2-hydroxy-3- isopropylaminopropoxy)benzofuran having a melting point of 75C.
Analysis for C,,H,,,0,N,=
Calcd. C 68.64, H 8.49, N 8.43;
Found C 68.50, H 8.52, N 8.21.
of 2-acetyl-5-hydroxy- I EXAMPLE 27 A mixture of 1.8 ,g. of 2-acetyl-6-hydroxybenzofuran, 18 ml. of epichlorohydrin and 100 mg. of piperidine hydrochloride was refluxed for 4 hours and then the solvent was evaporated. The resultant was shaken with 10 ml. of chloroform and 3 ml. of concentrated hydrochloric acid and washed with water. The chloroform layer was condensed to give 1.4 g. of 2-acetyl-6-(2-hydroxy- 3-chloropropoxy)benzofuran. The product thus obtained was dissolved in 50 m1. ofsec.-buty1amine and the solution was heated in a sealed tube at 105C. for 14 hours and then the excess of sec.-butylamine was evaporated. After collecting the materials dissolved into ether from the residue, ether was evaporated to give 1.1 g. of 2-(1-sec.-butylimino)ethyl-6-(2-hydroxy- 3-sec.-butylaminopropoxy)benzofuran as an oily substance.
Analysis for C,,H .,,0,N,; Calcd. C 69.97, H 8.95, N 7.77; Found C 69.75, H 8.84, N 7.86.
EXAMPLE 28 In 26ml. of n-amylamine was dissolved 1.3 g. of 2- acety1-5-(2-hydroxy-3-chloropropoxy)benzofuran prepared in the same manner as described in Example 26 and the solution was heated in a sealed tube at l 10C. for 12 hours and then the excess of amylamine was evaporated under a reduced pressure. After collecting the materials dissolved into hot petroleum ether, the petroleum ether layer was cooled to give 1.3 g. of 2-(1- amylimino)ethy1-5-(2-hydroxy 3-amylaminopropoxy)- benzofuran having a melting point of 70C.
Analysis for C H O N Calcd. C 71.10, H 9.34, N 7.21;
Found C 70.95, H 9.30, N 7.48.
EXAMPLE 29 ln 5 ml. ofethanol were dissolved 0.3 g. of 2-ace tyl-7- (2-hydr0xy-3-aminopropoxy)benzofuran and 1.0 g. of isopropyl bromide. The mixture was refluxed for 8 hours. After filtering the reaction mixture, the filtrate was condensed under a reduced pressure, dissolved in 5 hydrochloric acid and washed twice with each 30 ml. of ether The aqueous solution was made alkaline with 1.3 N aqueous sodium hydroxide solution and extracted twice with each 50 ml. of ether. The ether layer was washed with water and dried over anhydrous so dium sulfate, and then the solvent was evaporated under a reduced pressure to give 02 g. of yellow oily substance. The substance was allowed to stand to give 0.17 g. of 2-acetyl-7-(2-hydroxy-3-npropylarninopropoxy)benzofuran having w a melting point of 735 to 74.5C.
EXAMPLE '30 i To 6 ml. of methanol were added 0.6 g. of 2-acetyl-7- (2-hydroxy-3-aminopropoxy)benzofuran and 0.42 g. of isopropyl bromide. The mixture was heated in a sealed tube at 100C. for 8 hours. After filtering the reaction mixture, the solvent was evaporated. The resulting residue was dissolved in 10 ml. of 3 N hydrochloric acid. The solution was washed twice with-each 30 ml. of ether. made alkaline with 1.3 N aqueous sodium hydroxide solution and extracted three times with chloroform-ether. The solvent was evaporated from the extract under a reduced pressure to give 0.57 g. of faint yellow oily substance. The substance was allowed to stand to give 0.53 g. of 2-acetyl-7-(2-hydroxy-3- .isopropylaminopropoxy)benzofuran having a melting point of 113 to 115C.
EXAMPLE 31 To 2 ml; of ethanol were added 120 mg. of 2-acetyl-7-hydroxybenzofuran, 120 mg. of lisopropylamino-3-chloro-2-propanol hydrochloride and 84 mg. of powdery sodium hydroxide. The mixture was heated in a sealed tube at 70C. for 40 hours. After filtering the reaction mixture, the solvent was evaporated under a reduced pressure. The residue was washed with 10 ml. of cyclohexane and then 10 m1. of petroleum ether in order and dissolved in 1 ml. of ethyl acetate. The solution was subjected to thin layer chromatography (solid support Kieselgel P1 made by E. Merck, developer benzene-chloroform-methanol- 28% aqueous ammonia(17:4:3:0.4), eluant: chloroform) to give 31 mg. of 2-acetyl-7-(2-hydroxy-3- isopropyl-aminopropoxy)benzofuran having a melting point of 113 to 115C.
EXAMPLE 32 1n 2 ml. of dimethylformamide was dissolved 0.12 g.
of 2-acetyl-7-hydroxybenzofuran and thereto was added 0.42 g. of potassium carbonate. To the mixture was added 0.18 g. of 1-isopropylamino-2-hydroxy-3- -,chloropropane hydrochloride in portions (Stimes) over 1 hour with agitation at to C., and the mixture was heated with agitiation at 80 to 100C. for 8 hours. The reaction mixture was filtered and distilled under a reduced pressure. The residue was extracted with chloroform. The chloroform layer was separated and chloroform was evaporated. The residue was dissolved in 50 ml. of ether and then extracted with 3 N hydrochloric acid. The extract was made alkaline with 1.3 N aqueous sodium hydroxide solution and extracted with chloroform. The chloroform layer was washed with water, dried over anhydrous sodium sulfate and then the solvent was condensed. The resultant was subjected to thin layer chromatography (solid support: Kieselgel P1 made by E. Merck, developer: be nzene-chloroformmethanol-28 aqueous ammonia( l7:4:3:0.4), eluate; chloroform) to give 29 mg. of 2-acetyl-7-(Z-hydroxy-3-isopropylaminopropoxy)- benzofuran having a melting point of 1 13 to l 15C.
EXAMPLE 33 In a mixture of 1 ml. of acetone and 2 ml. of methanol was dissolved 0.2 g. of 2-(1-ethy1enedioxy)-ethyl-7- (2-hydroxy-3-aminopropoxy)benzofuran. To the mixture were added in. portions 0.2 g. of sodium borohydride with agitation under cooling and further 3 drops of acetic acid and 5 drops of concentrated hydrochloric acid in order. After filtering the mixture, the filtrate was distilled under a reduced pressure to give faint yellow crystallines. The product thus obtained was dissolved in ethyl acetate-methanol (2:1). The solutionwas filtered, distilled under a reduced pressure, made alkaline with 3 N aqueous sodium hydroxide solution and then extracted with ether. The ether layer was dried over anhydrous sodium sulfate and ether was.
evaporated to give 0.15 g. of 2-acetyl-7-(2-hydroxy-3- isopropylaminopropoxy)-benzofuran having a melting point of C.
EXAMPLE 34 In 30 ml. of methanol was dissolved 1.0 g. of 2-(1- ethylenedioxy)ethyl-7-(2-hydroxy-3-aminopropoxy)- benzofuran and thereto were added 10 ml. of acetone and 0.8 g. of% palladium-charcoal. To the mixture was added hydrogen gas at a room temperature under atmospheric pressure until theoretical amount of hydrogen was absorbed. The reaction mixture was filtered and distilled under a reduced pressure to give 1.0 g. of faint yellow oily substance. The substance was dissolved in 20 ml. of ethanol and thereto was added 0.1 ml. of concentrated hydrochloric acid. The mixture was agitated at a room temperature for 30 minutes and then the solvent was evaporated under a reduced pressure. To the residue was added 5 ml. of 3 N hydrochloric acid and the mixture was extracted with ether, made alkaline with 1.3 N aqueous sodium hydroxide solution and extracted twice with ether'chloroform (1:1). The solvent was evaporated to give 0.97 g. of 2-acetyl-7-( 2- hydroxy-3-isopropylaminopropoxy)-benzofuran having a melting point of 113 to 115C.
EXAMPLE 35 A mixture of 1.0 g. of 3-isopropyl-5-(2-acetyl-7- benzofuranoxymethyl)oxazolidone and ml. of 10 N aqueous sodium hydroxide solution was heated with agitation at 150C. for 30 minutes. To the reaction mixture was added 100 ml. of water and the mixture was made slightly alkaline with a diluted hydrochloric acid and extracted with chloroformether. The organic layer was dried over anhydrous sodium sulfate and the solvent was evaporated under a reduced pressure to give 0.6 g. of
point of 113 to 115C.
EXAMPLE 36 To 10 ml. of 10% hydrochloric acid was added 1.0 g. of 2-phenyl-3-isopropyl-5-(2-acetyl-7- benzofuranoxymethyl)oxazolidine and the mixture was heated at 90 to 95C. for 1 hour. After cooling, the reaction mixture was made alkaline with 1.3 N aqueous sodium hydroxide solution and extracted with etherchloroform. The organic layer was washed with water, dried over anhydrous sodium sulfate and the solvent was evaporated under a reduced pressure to give 0.9 g. of 2-acetyl-7-(2-hydroxy-3-isopropylaminopropoxy)- benzofuran having a melting point of 113 to 115C.
EXAMPLE 37 A mixture of 2.0 g. of 2-acetyl-7-[2-hydroxy-3N- acetyl-N-isopropyl)aminopropoxy1benzofuran and 1.0 ml. of 2 N hydrochloric acid was heated at 70 to 80C. for 2 hours. After cooling, the reaction mixture was washed with ether, made alkaline with 1.3 N aqueous sodium hydroxide solution and extracted with etherchloroform. The organic layer was washed with water, dried over anhydrous sodium sulfate and the solvent was evaporated under a reduced pressure to give 1.92 g. of 2-acetyl-7-(Z-hydroxy-3-isopropylaminopropoxy)benzofuran having a melting point of 113 to 1 C.
EXAMPLE 38 In 10 ml. of 10% aqueous dioxane was dissolved 1.0 g. of 2-(1-ethylenedioxy)ethyl-7-(2-oxo-3- 2-acetyl-7-(2-hydroxy-3- isopropylaminopropoxy)benzofuran having a melting isopropylaminopropoxy)benzofuran and thereto was added in portions mg. of sodium borohydride with agitation under cooling. The mixture was reacted at a room temperature for 30 minutes and thereto was added 4 drops of acetic acid. After filtration, 4 drops of concentrated hydrochloric acid was added to the filtrate and the mixture was agitated at a room temperature for 15 minutes and then the solvent was evaporated under a reduced pressure. To the residue was added 1.3 N aqueous sodium hydroxide solution to make alkaline and then the mixture was extracted with ether-chloroform. The organic layer was washed with water, dried over anhydrous sodium sulfate and the solvent was evaporated under a reduced pressure. The residue was allowed to stand at a room temperature to give 0.9 g. of 2-acetyl-7-(2-hydroxy-3- isopropylaminopropoxy)benzofuran having a melting point of 113 to 115C.
EXAMPLE 39 In 30 ml. of ethanol was dissolved 1.0 g. of 2-(1- ethylenedioxy)ethyl-7-[2-hydroxy-3-(N-benzyl-N- isopropyl)aminopropoxylbenzofuran and thereto was added 0.5 g. of 5% palladium-charcoal. To the mixture was added hydrogen gas at a room temperature under atmospheric pressure until theoretical amount of hydrogen gas was absorbed. After filtration, the filtrate was distilled under areduced pressure to give 0.65 g. of clear oily substance. The substance thus obtained was dissolved in 5 ml. of ethanol and thereto was added 2 drops of concentrated hydrochloric acid. The mixture was agitated at a room temperature for 30 minutes and then the solvent was evaporated under a reduced pressure. To the residue was added 5 ml. of 3 N hydrochloric acid. The mixture was extracted three times with each 15 ml. of ether, made alkaline with 1.3 N
aqueous sodium hydroxide solution, extracted twice with each 25 ml. of ether. The solvent was evaporated to give 0.51 g. of 2-acetyl-7-(2-hydroxy-3- isopropylaminopropoxy)benzofuran having a melting point of 113 to 115C.
EXAMPLE 40 To 20 ml. of ethanol was suspended 0.25 g. of platinum oxide and thereto was added hydrogen gas at a room temperature. To the mixture was added a solu tion of 0.6 g. of 2-( l-ethylenedioxy)ethyl-7-(2-oxo-3- hydroxyiminopropoxy)benzofuran in 10 ml. of ethanol and 5 ml. of acetone. To the mixture was added with agitation hydrogen gas at a room temperature under atmospheric pressure until theoretical amount of hydrogen was absorbed. After filtration, to the filtrate was added 4 drops of concentrated hydrochloric acid. The mixture was agitated at a room temperature for 15 minutes and then the solvent was evaporated under the reduced pressure. To the residue was added 10 ml. of 0.5 N hydrochloric acid and the mixture was extracted with ether. The aqueous layer was made alkaline with 2 N aqueous sodium hydroxide solution and extracted with ether. The ether layer was washed with water, dried over anhydrous sodium sulfate and the solvent was evaporated under a reduced pressure to give 0.45 g. of 2-acetyl-7-(2hydroxy-S-isopropylaminopropoxy)- benzofuran having a melting point of 1 13 to 1 15C.
EXAMPLE 41 In 50 ml. of ethanol were dissolved 2.3 g. of 2-(1- tracted with ether. The ether layer was washed with water, dried over anhydrous sodium sulfate and the solvent was evaporated under a reduced pressure to give 0.9 g. of 2-acety1-7-(2-hydroxy-3- isopropylaminopropoxy)benzofuran having a melting point of 113 to 115C.
EXAMPLE 42 To 30 g. of acetic acid were added 1 g. of 2 (lethylenedioxy )ethyl-7-( Z-cyano-2-hydroxyethoxy)- benzofuran, 20 g. of acetone and 1.2 g. of palladium charcoa1 and thereto was added with agitation hydrogen gas at a room temperature under atmospheric pressure for 24 hours. The mixture was filtered and the solvent was evaporated under a reduced pressure. To the residue was added 40 m1. of 1.3 N aqueous sodium hydroxide solution and the mixture was refluxed for .15 minutes. After cooling, the mixture was extracted with ether-chloroform and the organic layer was washed with water, dried over anhydrous sodium hydroxide solution and the solvent was evaporated under a reduced pressure to give 0.3 g. of 2-acetyl-7-(2-hydroxy-3- isopropylaminopropoxy)benzofuran having a melting point of 113 to 115C.
EXAMPLE 43 With respect to the present benzofuran derivatives and Propranolol which has been widely used as an adrenergic blocking agent, there was tested isoproterenol antagonism concerning myocardial contractile force; heart rate and diastolic blood pressure in anesthetized dogs (Cf. The Journal of Pharmacology and Experimental Therapeutics, Vol. 176, No. 2, pages 339 to 349, 1971).
The male and female dogs weighing betwen 9 and 20 kg. were used. Doses of isoproterenol and compounds to be tested were 0.3 ugJkg. and 0.01 to 100 rig/kg..
respectively. The results are shown in Table 1.
Compound No. l 2-(1-isopropylimino1e\hy1-7-(I-hydroxy-3-isopropyluminopropoxy)henzolurun Compound No. 2 2-nctyl-4-(2-hydroxy-3-tert.-hutyluminu-prupuxy)hcnzofurun Compound No. 3: 2-ucetyl-7-(2-hydroxy-3-isupropylumino-propuxylhcnzufurun 2-ucety1-7-( 2-hydroxy-3-ter1.butyl-uminopropoxy )benznl'urun Com ound No. 5
Z-car ethdiyJ-iZ-hydruxy-Il-isnpropyl-uminopropoxylbenzofunm Compound No. 6
2-( 1 -ls'oprnpyliminu lethyl-4-t 2-hydroxy-3Jsopiopylaminopropoxy )henzofurun Compound No. 7
2-acetyl-7-( 2-hydroxy-3-sec.-butylamino-propoxy )benzofuran "index value when the value of Proprunolol is 1.
EXAMPLE 44 With respect to the present benzofuran derivatives 5 and Propranolol, there was tested isoproterenol antagonism concerning myocardial contractile force and heart ratein isolated guinea-pig atria (Cf. The Journal of Pharmacology and Experimental Therapeutics, Vol. 168, No. 1, pages 116 to 126, 1969).
isolated guinea-pig atrium was mounted in a chamber containing Ringer-Locke solution (37C.), through which 95% O -5% CO was continuously bubbled. l X 10' g./ml. of isoproterenol was used. 50% inhibition of isoproterenol responses was investigated. The results are shown in Table ll.
Compound Nos. are the same as defined in Table 1.
30 EXAMPLE 45 Acute toxicity of the present banxofuran derivatives was tested in mice by intravenous injection. The results are shown in Table 111. 35
Table 111 Compounds 0 Propranolol Compound Nos. 1 to 7 are the same as defined in 'l'a hle 1. Compound No. 8 2-ethyi-4-ncetyl-74 Z-hyd roxy-3-isopropylaminopropuxy )benzu fu ran.
What is claimed is: l. A benzofuran derivative of the formula:
OOHaCIICHzNHR A o 11 wherein A is COR',
R! -=NR or ethyl; B is hydrogen atom when A is -COR', or
or -COR"' substituted at 3 or 4 position of benzofuran nucleus when A is ethyl; R is alkyl having 1 to 5 carbon atoms; R is alkyl having 1 to 4 carbon atoms, alkoxy having 1 to 3 carbon atoms or phenyl group; R" is alkyl having I to 4 carbon atoms, phenyl or phenylalkyl wherein the alkyl moietyhas l to 2 carbon atoms; and a pharmaceutically acceptable acid addition salt thereof.
2. A benzofuran derivative according to claim 1, wherein R is branched alkyl having 3 to 4 carbon atoms.
3. A benzofuran derivative according to claim 1 wherein A is COR'.
4. 2-acetyl-7-(Z-hydroxy-3 -isopropylaminopropyl)- benzofuran.
5. 2-acetyl-7-(2-hydroxy-3-tertiary butylaminopropoxy)benzofuran.
2-carbethoxy-7-(2-hydroxy-3- isopropylaminopropoxy)benzofuran.
7. 2-benzoyl-7-(2-hydroxy-3-isopropylaminopropoxy)benzofuran.
8. 2-acetyl-7-(2-hydroxy-3-secondary butylaminopropoxy)benzofuran.
2-acetyl-4-(2-hydroxy-3-tertiary butylaminopropoxy)benzofuran.
10. 2-(l-isopropylimino)ethyl-7-(2-hydroxy-3- isopropylaminopropoxy)benzofuran.
l1. 2-( l-isopropylimino)ethyl-4-(2-hydroxy-3- isopropylaminopropoxy)henzofuran.
12. A benzofuran derivative of the following formula:
wherein R is lower alkyl having 1 to 4 carbon atoms lower alkoxy having 1 to 3 carbon atoms or phenyl; R is lower alkyl having 1 to 5 carbon atoms and the substituted propoxy group is on the 3, 4, 5. 6 or 7 position of the benzofuran ring; and the acid salts thereof.
13. The hydrochloride salt of the compound of claim 12 wherein R'CO is acetyl; R is isopropyl and the substituted propoxy group is on the 5 position of the benzofuran ring.
14. The benzofuran derivative of claim 12 wherein R'CO is acetyl; R is tertiary butyl and the substituted propoxy group is on the 3 position of the benzofuran ring.
15. The benzofuran derivative of claim 12 wherein RCO is acetyl; R is tertiary butyl and the substituted propoxy group is on the 6 position of the benzofuran ring;
16. The benzofuran derivative of claim 12 wherein RCO is acetyl; R is n-propyl and the substituted propoxy group is on the 7 position of the benzofuran ring.
17. The hydrochloride salt of the compound of claim 4.
18. The hydrochloride salt of the compound of claim 5.
19. The hydrochloride salt of the compound of claim 9.
20. The hydrochloride salt of the compound of claim 6.
21. The benzofuran derivative of claim 12 selected from the group consisting of:
l. 2-acetyl-7-(2-hydroxy-3-isopropylaminopropoxy benzofuran and its hydrochloride;
2. 2-acetyl-7-(2-hydroxy-3-tert.-butylaminopropoxy)benzofuran and its hydrochloride;
3. 2-acetyl-4-(2-hydroxy-3-tert.-butylaminopropoxy)benzofuran and its hydrochloride;
4. 2-carbeth0xy-7-(2-hydroxy-3- isopropylaminopropoxy)benzofuran and its hydrochloride;
5. 2-benzoyl-7-(2-hydroxy-3-isopropylaminopropoxy)benzofuran;
6. 2-acetyl-5-(2-hydroxy-3-isopropylaminopropoxy)- benzofuran hydrochloride;
7. 2-acetyl-7-(2-hydroxy-sec.-butylaminopropoxy)- benzofuran;
8. 2-acetyl-3-(2-hydroxy-3-tert.-butylaminopropoxy)benzofuran;
9. 2-acetyl-6-(2-hydroxy-3-tert.-butylaminopropoxy)benzofuran; and
10. 2-acetyl-7-(2-hydroxy-3-n-propylaminopropoxy)benzofuran.
UNITED STATES PATENT OFFICE CERTIFICATE OF CORRECTION PATENT NO. 3,853,923
DATED DECEMBER 10, 1974 |NVENTOR(S) KIYOSHI ITO et al It is certified that error appears in the above-identified patent and that said Letters Patent are hereby corrected as shown below;
Column 6, line 4, change "anesthetic acitvit" to anesthetic activity Column 15, line 41, change "isopropyl bromide" to n-propyl bromide Column 21, Claim 4, change "2-acetyl-7-(2-hydroxy-3- isopropylaminopropyl)benzofuran" to 2-acetyl-7-(2-hydroXy- 3-isopropylaminopropoxy)benzofuran Column 21, Claim 12, the formula should read as follows:
OCH CHCH NHR (SEAL) Attest:
C. MARSHALL DANN RUTH C. MASON Commissioner of Patents Attesting Officer and Trademarks

Claims (30)

1. A BENZOFURAN DERIIVATIVE OF THE FORMULA:
2. 2-acetyl-7-(2-hydroxy-3-tert.-butylaminopropoxy)benzofuran and its hydrochloride;
2. A benzofuran derivative according to claim 1, wherein R is branched alkyl having 3 to 4 carbon atoms.
3. A benzofuran derivative according to claim 1, wherein A is -COR''.
3. 2-acetyl-4-(2-hydroxy-3-tert.-butylaminopropoxy)benzofuran and its hydrochloride;
4. 2-carbethoxy-7-(2-hydroxy-3-isopropylaminopropoxy)benzofuran and its hydrochloride;
4. 2-acetyl-7-(2-hydroxy-3-isopropylaminopropyl)benzofuran.
5. 2-acetyl-7-(2-hydroxy-3-tertiary butylaminopropoxy)benzofuran.
5. 2-benzoyl-7-(2-hydroxy-3-isopropylaminopropoxy)benzofuran;
6. 2-acetyl-5-(2-hydroxy-3-isopropylaminopropoxy)benzofuran hydrochloride;
6. 2-carbethoxy-7-(2-hydroxy-3-isopropylaminopropoxy)benzofuran.
7. 2-benzoyl-7-(2-hydroxy-3-isopropylaminopropoxy)benzofuran.
7. 2-acetyl-7-(2-hydroxy-sec.-butylaminopropoxy)benzofuran;
8. 2-acetyl-3-(2-hydroxy-3-tert.-butylaminopropoxy)benzofuran;
8. 2-acetyl-7-(2-hydroxy-3-secondary butylaminopropoxy)benzofuran.
9. 2-acetyl-4-(2-hydroxy-3-tertiary butylaminopropoxy)benzofuran.
9. 2-acetyl-6-(2-hydroxy-3-tert.-butylaminopropoxy)benzofuran; and
10. 2-acetyl-7-(2-hydroxy-3-n-propylaminopropoxy)benzofuran.
10. 2-(1-isopropylimino)ethyl-7-(2-hydroxy-3-isopropylaminopropoxy)benzofuran.
11. 2-(1-isopropylimino)ethyl-4-(2-hydroxy-3-isopropylaminopropoxy)benzofuran.
12. A benzofuran derivative of the following formula:
13. The hydrochloride salt of the compound of claim 12 wherein R''CO is acetyl; R is isopropyl and the substituted propoxy group is on the 5 position of the benzofuran ring.
14. The benzofuran derivative of claim 12 wherein R''CO is acetyl; R is tertiary butyl and the substituted propoxy group is on the 3 position of the benzofuran ring.
15. The benzofuran derivative of claim 12 wherein R''CO is acetyl; R is tertiary butyl and the substituted propoxy group is on the 6 position of the benzofuran ring.
16. The benzofuran derivative of claim 12 wherein R''CO is acetyl; R is n-propyl and the substituted propoxy group is on the 7 position of the benzofuran ring.
17. The hydrochloride salt of the compound of claim 4.
18. The hydrochloride salt of the compound of claim 5.
19. The hydrochloride salt of the compound of claim 9.
20. The hydrochloride salt of the compound of claim 6.
21. The benzofuran derivative of claim 12 selected from the group consisting of:
US00251454A 1971-05-13 1972-05-08 2-substituted-(2-hydroxy-3-lower alkaminopropoxy)-benzofurans Expired - Lifetime US3853923A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP3214571 1971-05-13
JP5233371A JPS5020062B1 (en) 1971-07-14 1971-07-14
JP8610971A JPS5020063B2 (en) 1971-10-28 1971-10-28
JP439572A JPS5529993B2 (en) 1972-01-06 1972-01-06

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US05447060 Division 1974-02-28

Publications (1)

Publication Number Publication Date
US3853923A true US3853923A (en) 1974-12-10

Family

ID=27454077

Family Applications (1)

Application Number Title Priority Date Filing Date
US00251454A Expired - Lifetime US3853923A (en) 1971-05-13 1972-05-08 2-substituted-(2-hydroxy-3-lower alkaminopropoxy)-benzofurans

Country Status (8)

Country Link
US (1) US3853923A (en)
BE (1) BE783440A (en)
CA (1) CA989411A (en)
CH (1) CH587261A5 (en)
DE (1) DE2223184C3 (en)
FR (1) FR2137901B1 (en)
GB (1) GB1380129A (en)
NL (1) NL166939C (en)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5639015A (en) * 1979-09-06 1981-04-14 Kaken Pharmaceut Co Ltd Ophthalmic solution for regulating intraocular tension
US4485111A (en) * 1981-10-30 1984-11-27 Laboratories Debat Derivatives of 3-amino-1-benzofuranyloxy-2-propanol useful as cardioselective beta-blocking agents
EP0156331A2 (en) * 1984-03-27 1985-10-02 Kaken Pharmaceutical Co., Ltd. Benzofuran derivatives, processes for preparing the same and antihypertensive agents containing the same
US5192799A (en) * 1987-12-11 1993-03-09 Mitsui Petrochemical Industries, Ltd. Coumaran group containing amine compounds and their acid addition salts and quaternary ammonium salts and the use thereof as anti arrhythmic agents and as psychotropic agents
WO2004017964A1 (en) 2002-08-19 2004-03-04 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
WO2007024945A1 (en) 2005-08-25 2007-03-01 Novartis Ag Condensed imidazolo derivatives for the inhibition of aldosterone synthase and aromatase
WO2007062314A2 (en) 2005-11-23 2007-05-31 Bristol-Myers Squibb Company Heterocyclic cetp inhibitors
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
EP2392567A1 (en) 2005-10-21 2011-12-07 Bristol-Myers Squibb Company Benzothiazine derivatives and their use as lxr modulators
WO2014170786A1 (en) 2013-04-17 2014-10-23 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CN107827849A (en) * 2017-11-14 2018-03-23 沈阳药科大学 6 [2 hydroxyl 3 (alkylamino radical) propoxyl group] benzofuran compounds and its application
CN107857748A (en) * 2017-11-14 2018-03-30 沈阳药科大学 5 [2 hydroxyl 3 (alkylamino radical) propoxyl group] benzofuran compounds and its application
CN107935972A (en) * 2017-11-14 2018-04-20 沈阳药科大学 5 [2 hydroxyl 3 (isopropylamine base) propoxyl group] benzofuran derivatives and its application
US10005750B2 (en) 2010-10-06 2018-06-26 J-Pharma Co., Ltd. Developing potent urate transporter inhibitors: compounds designed for their uricosuric action
WO2020150473A2 (en) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Pcsk9 inhibitors and methods of use thereof

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2457866A1 (en) * 1979-05-29 1980-12-26 Anvar NOVEL DERIVATIVES OF CYANO-2 HYDROXY-3 BENZOFURANNE AND BENZO (B) THIOPHENE, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS
JPS58157784A (en) * 1982-03-16 1983-09-19 Kaken Pharmaceut Co Ltd Preparation of optically active (s)-(+)-2-acetyl-7-(2,3-epoxypropoxy)benzofuran
BR9916318A (en) 1998-12-18 2001-08-14 Basilea Pharmaceutica Ag Bicyclic compounds

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3340266A (en) * 1963-07-30 1967-09-05 Ici Ltd (3-amino-2-hydroxypropoxy)-benzoheterocyclic derivatives

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3340266A (en) * 1963-07-30 1967-09-05 Ici Ltd (3-amino-2-hydroxypropoxy)-benzoheterocyclic derivatives

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5639015A (en) * 1979-09-06 1981-04-14 Kaken Pharmaceut Co Ltd Ophthalmic solution for regulating intraocular tension
JPS6256130B2 (en) * 1979-09-06 1987-11-24 Kaken Pharma Co Ltd
US4485111A (en) * 1981-10-30 1984-11-27 Laboratories Debat Derivatives of 3-amino-1-benzofuranyloxy-2-propanol useful as cardioselective beta-blocking agents
EP0156331A2 (en) * 1984-03-27 1985-10-02 Kaken Pharmaceutical Co., Ltd. Benzofuran derivatives, processes for preparing the same and antihypertensive agents containing the same
EP0156331A3 (en) * 1984-03-27 1986-08-20 Kaken Pharmaceutical Co., Ltd. Benzuforan derivatives, processes for preparing the same and antihypertensive agents containing the same
US5192799A (en) * 1987-12-11 1993-03-09 Mitsui Petrochemical Industries, Ltd. Coumaran group containing amine compounds and their acid addition salts and quaternary ammonium salts and the use thereof as anti arrhythmic agents and as psychotropic agents
WO2004017964A1 (en) 2002-08-19 2004-03-04 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
EP2256118A1 (en) 2005-08-25 2010-12-01 Novartis AG Condensed imidazolo derivatives for the inhibition of aromatase
WO2007024945A1 (en) 2005-08-25 2007-03-01 Novartis Ag Condensed imidazolo derivatives for the inhibition of aldosterone synthase and aromatase
EP2270011A1 (en) 2005-08-25 2011-01-05 Novartis AG Condensed imidazolo derivatives for the inhibition of aromatase
EP2392567A1 (en) 2005-10-21 2011-12-07 Bristol-Myers Squibb Company Benzothiazine derivatives and their use as lxr modulators
WO2007062314A2 (en) 2005-11-23 2007-05-31 Bristol-Myers Squibb Company Heterocyclic cetp inhibitors
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
US10005750B2 (en) 2010-10-06 2018-06-26 J-Pharma Co., Ltd. Developing potent urate transporter inhibitors: compounds designed for their uricosuric action
WO2014170786A1 (en) 2013-04-17 2014-10-23 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CN107857748A (en) * 2017-11-14 2018-03-30 沈阳药科大学 5 [2 hydroxyl 3 (alkylamino radical) propoxyl group] benzofuran compounds and its application
CN107935972A (en) * 2017-11-14 2018-04-20 沈阳药科大学 5 [2 hydroxyl 3 (isopropylamine base) propoxyl group] benzofuran derivatives and its application
CN107827849A (en) * 2017-11-14 2018-03-23 沈阳药科大学 6 [2 hydroxyl 3 (alkylamino radical) propoxyl group] benzofuran compounds and its application
CN107857748B (en) * 2017-11-14 2020-06-02 沈阳药科大学 5- [ 2-hydroxy-3- (alkylamino) propoxy ] benzofuran compound and application thereof
WO2020150473A2 (en) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Pcsk9 inhibitors and methods of use thereof

Also Published As

Publication number Publication date
NL166939C (en) 1981-10-15
NL166939B (en) 1981-05-15
CA989411A (en) 1976-05-18
CH587261A5 (en) 1977-04-29
GB1380129A (en) 1975-01-08
DE2223184A1 (en) 1972-11-23
NL7206433A (en) 1972-11-15
FR2137901B1 (en) 1975-10-31
BE783440A (en) 1972-09-01
DE2223184C3 (en) 1980-04-30
DE2223184B2 (en) 1979-08-16
FR2137901A1 (en) 1972-12-29

Similar Documents

Publication Publication Date Title
US3853923A (en) 2-substituted-(2-hydroxy-3-lower alkaminopropoxy)-benzofurans
US4582847A (en) 4-chloro-2-phenylimidazole-5-acetic acid derivatives and use as diuretics and hypotensives
US4207324A (en) 1,2-Di-Substituted-4-haloimidazole-5-acetic acid derivatives and their use
CA1072090A (en) Trans-4-amino-3,4-dihydro-2h-benzo-/b/-pyran-3-ol compounds
CA1048497A (en) Benzcycloamide derivatives
EP0593478B1 (en) Leukotriene b 4 antagonists
US4724238A (en) Method of treating inflammatory diseases with labdan derivatives
US3910952A (en) Novel substituted indole compound, process for the preparation and therapeutic compositions containing it
US4056626A (en) Pharmaceutical composition containing benzofuran derivative
US3953456A (en) Carbostyril derivatives and process for preparing the same
US4395559A (en) 2,3-Indoledione derivatives
IL33846A (en) Derivatives of 1-thiachromone and 4-thionchromone,their preparation and pharmaceutical compositions containing them
US3192253A (en) N-substituted methoxyphenoxy-ethylamines
US4539326A (en) 5-Oxo-5H-(1)benzopyrano(2,3-b)pyridine derivatives, their production and use as anti-inflammatory agents
US4512990A (en) Benzthiazine analogs as antiinflammatory agents
CA1235703A (en) 6-substituted 6h-dibenzo/b.d/pyran derivatives and process for their preparation
US4209527A (en) Benzimidazolone derivatives
US4536503A (en) Naphthoxyalkylamines and related compounds as antiinflammatory agents
US4670439A (en) 2H-1-benzopyran-2-one derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
US4785018A (en) Glycine derivatives
US3665074A (en) Certain benzofuran derivatives useful for relief of pain,inflammation,pyresis and tussive irritation
US3542785A (en) 2-hydroxy-4-aryl-quinolines
US3647802A (en) 2-amino-4-aryl-3 4-dihydroquinolines
US3637759A (en) Chromanes
EP0009608A1 (en) N-Phenethylacetamide compounds, processes for their preparation and therapeutic compositions containing them